219 related articles for article (PubMed ID: 22840683)
21. The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial.
Clair DG; Adams J; Reen B; Feldman R; Starr J; Diaz-Cartelle J; Dawkins KD
J Endovasc Ther; 2014 Apr; 21(2):213-22. PubMed ID: 24754280
[TBL] [Abstract][Full Text] [Related]
22. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
23. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents.
Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G
Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060
[TBL] [Abstract][Full Text] [Related]
24. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
25. Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions.
Zamani N; Sharath SE; Browder RC; Barshes NR; Braun JD; Mills JL; Kougias P; Younes HK
Ann Vasc Surg; 2021 Feb; 71():298-307. PubMed ID: 32891746
[TBL] [Abstract][Full Text] [Related]
26. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
27. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
[TBL] [Abstract][Full Text] [Related]
29. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.
Garcia L; Jaff MR; Metzger C; Sedillo G; Pershad A; Zidar F; Patlola R; Wilkins RG; Espinoza A; Iskander A; Khammar GS; Khatib Y; Beasley R; Makam S; Kovach R; Kamat S; Leon LR; Eaves WB; Popma JJ; Mauri L; Donohoe D; Base CC; Rosenfield K;
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969545
[TBL] [Abstract][Full Text] [Related]
30. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
[TBL] [Abstract][Full Text] [Related]
31. Deployment of self-expandable stents for complex proximal superficial femoral artery lesions involving the femoral bifurcation with or without jailed deep femoral artery.
Yamawaki M; Hirano K; Nakano M; Sakamoto Y; Takimura H; Araki M; Ishimori H; Ito Y; Tsukahara R; Muramatsu T
Catheter Cardiovasc Interv; 2013 May; 81(6):1031-41. PubMed ID: 22639451
[TBL] [Abstract][Full Text] [Related]
32. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.
Bosiers M; Torsello G; Gissler HM; Ruef J; Müller-Hülsbeck S; Jahnke T; Peeters P; Daenens K; Lammer J; Schroë H; Mathias K; Koppensteiner R; Vermassen F; Scheinert D
J Endovasc Ther; 2009 Jun; 16(3):261-9. PubMed ID: 19642788
[TBL] [Abstract][Full Text] [Related]
33. The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center.
Kim W; Gandhi RT; Peña CS; Herrera RE; Schernthaner MB; Acuña JM; Becerra VN; Katzen BT
J Vasc Interv Radiol; 2016 Oct; 27(10):1494-501. PubMed ID: 27522274
[TBL] [Abstract][Full Text] [Related]
34. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry.
Scheinert D; Werner M; Scheinert S; Paetzold A; Banning-Eichenseer U; Piorkowski M; Ulrich M; Bausback Y; Bräunlich S; Schmidt A
JACC Cardiovasc Interv; 2013 Jan; 6(1):65-71. PubMed ID: 23347863
[TBL] [Abstract][Full Text] [Related]
35. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.
Dake MD; Scheinert D; Tepe G; Tessarek J; Fanelli F; Bosiers M; Ruhlmann C; Kavteladze Z; Lottes AE; Ragheb AO; Zeller T;
J Endovasc Ther; 2011 Oct; 18(5):613-23. PubMed ID: 21992630
[TBL] [Abstract][Full Text] [Related]
36. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.
Gray WA; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Bachinsky W; Rivera E; Tauth J; Patarca R; Massaro J; Stoll HP; Jaff MR;
J Vasc Interv Radiol; 2015 Jan; 26(1):21-8. PubMed ID: 25454735
[TBL] [Abstract][Full Text] [Related]
37. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
38. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
[TBL] [Abstract][Full Text] [Related]
39. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
[TBL] [Abstract][Full Text] [Related]
40. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft.
Farraj N; Srivastava A; Pershad A
J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
